182 related articles for article (PubMed ID: 29258398)
1. Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer.
Lyon DE; Starkweather A; Yao Y; Garrett T; Kelly DL; Menzies V; Dereziński P; Datta S; Kumar S; Jackson-Cook C
Biol Res Nurs; 2018 Mar; 20(2):227-236. PubMed ID: 29258398
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications.
Lyon DE; Yao Y; Garrett T; Kelly DL; Cousin L; Archer KJ
BMC Womens Health; 2023 May; 23(1):221. PubMed ID: 37138260
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors.
Li H; Lockwood MB; Schlaeger JM; Liu T; Danciu OC; Doorenbos AZ
Pain Manag Nurs; 2023 Feb; 24(1):52-59. PubMed ID: 36229337
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Pathways Associated With Psychoneurological Symptoms in Children With Cancer Receiving Chemotherapy.
Bai J; Withycombe J; Eldridge RC
Biol Res Nurs; 2022 Jul; 24(3):281-293. PubMed ID: 35285272
[TBL] [Abstract][Full Text] [Related]
5. Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.
Alhareeri AA; Archer KJ; Fu H; Lyon DE; Elswick RK; Kelly DL; Starkweather AR; Elmore LW; Bokhari YA; Jackson-Cook CK
Breast Cancer Res; 2020 Dec; 22(1):137. PubMed ID: 33276807
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
J Clin Nurs; 2019 Dec; 28(23-24):4560-4571. PubMed ID: 31469461
[TBL] [Abstract][Full Text] [Related]
8. Perceived cognitive changes with chemotherapy for breast cancer: A pilot study.
Piacentine LB; Miller JF; Haberlein S; Bloom AS
Appl Nurs Res; 2016 Feb; 29():9-11. PubMed ID: 26856481
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy.
Onesti CE; Boemer F; Josse C; Leduc S; Bours V; Jerusalem G
J Transl Med; 2019 Jul; 17(1):239. PubMed ID: 31337401
[TBL] [Abstract][Full Text] [Related]
10. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Acupuncture and Exploration of Metabolomic Alterations for Psychoneurological Symptoms Among Breast Cancer Survivors.
Li H; Schlaeger JM; Patil CL; Danciu OC; Xia Y; Sun J; Doorenbos AZ
Biol Res Nurs; 2023 Apr; 25(2):326-335. PubMed ID: 36306737
[TBL] [Abstract][Full Text] [Related]
12. Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.
Sun Y; Kim JH; Vangipuram K; Hayes DF; Smith EML; Yeomans L; Henry NL; Stringer KA; Hertz DL
Breast Cancer Res Treat; 2018 Oct; 171(3):657-666. PubMed ID: 29946863
[TBL] [Abstract][Full Text] [Related]
13. Psychoneurological symptom cluster trajectories in individuals treated for early-stage breast cancer.
Grayson S; Sereika S; Conley Y; Bender C; Carr K; Wesmiller S
Support Care Cancer; 2023 Sep; 31(10):563. PubMed ID: 37676346
[TBL] [Abstract][Full Text] [Related]
14. Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.
Madssen TS; Thune I; Flote VG; Lundgren S; Bertheussen GF; Frydenberg H; Wist E; Schlichting E; Schäfer H; Fjøsne HE; Vettukattil R; Lømo J; Bathen TF; Giskeødegård GF
Br J Cancer; 2018 Oct; 119(9):1144-1154. PubMed ID: 30401977
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.
Wei S; Liu L; Zhang J; Bowers J; Gowda GA; Seeger H; Fehm T; Neubauer HJ; Vogel U; Clare SE; Raftery D
Mol Oncol; 2013 Jun; 7(3):297-307. PubMed ID: 23142658
[TBL] [Abstract][Full Text] [Related]
16. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer.
Starkweather A; Kelly DL; Thacker L; Wright ML; Jackson-Cook CK; Lyon DE
Support Care Cancer; 2017 Jan; 25(1):167-176. PubMed ID: 27599815
[TBL] [Abstract][Full Text] [Related]
17. Pain and inflammation in women with early-stage breast cancer prior to induction of chemotherapy.
Starkweather AR; Lyon DE; Schubert CM
Biol Res Nurs; 2013 Apr; 15(2):234-41. PubMed ID: 22084403
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study of Proinflammatory Cytokines and Fatigue in Women With Breast Cancer During Chemotherapy.
Raudonis BM; Kelley IH; Rowe N; Ellis J
Cancer Nurs; 2017; 40(4):323-331. PubMed ID: 27351141
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.
Pertl MM; Hevey D; Boyle NT; Hughes MM; Collier S; O'Dwyer AM; Harkin A; Kennedy MJ; Connor TJ
Brain Behav Immun; 2013 Nov; 34():108-19. PubMed ID: 23928287
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
